pro-docosapentaenoic acid
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2004 (NCT00312455)
Timeline
2000s
- Jan 1, 2004
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Diacylglycerol kinase 1INHIBITOR
DGK inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pro-docosapentaenoic acid
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06533891 | N/A | Feb 29, 2020 | University of Arizona |
| NCT04088240 | N/A | Sep 4, 2019 | University of Arizona |
| NCT00312455 | Phase 2 | Jul 1, 2004 | Department of Veteran Affairs, National Institute on Drug Abuse (NIDA) |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Arizona | Academic/Hospital | 2 | 2 | 1 | 2019 |
| Department of Veteran Affairs | Government | 1 | 0 | 1 | 2004 |
| National Institute on Drug Abuse (NIDA) | Government | 1 | 1 | 1 | 2004 |
3 organizations
Page 1 / 1